EGFR and neoplasm: Epidermal growth factor receptor (EGFR; also known as ERBB1/HER1) is often expressed at higher levels in triple-negative tumours than in HR+ tumours [11], though expression levels vary, with up to ~ 80% of TNBC cases reported as being EGFR+ [12].